Back to mobile site

Maxim Group Downgrades Galmed Pharmaceuticals (GLMD) to Hold

February 14, 2018 9:06 AM EST Send to a Friend
Maxim Group downgraded Galmed Pharmaceuticals (NASDAQ: GLMD) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login